Table 4.
Results of three prognostic models derived by Kaplan‐Meier survival analysis
| Model | Baseline variables | Interim variables | n | Three‐year PFS, N (%) | P‐Valuea |
|---|---|---|---|---|---|
| Model 1 | TLG0 ≤ 1036.6 | TLG1 ≥ 14.068 | 32 | 31 (96.90) | 0.157 |
| TLG1 > 14.068 | 5 | 4 (80.00) | |||
| Total | 37 | 35 (94.60) | |||
| TLG0 > 1036.6 | TLG1 ≤ 14.068 | 30 | 22 (73.30) | 0.000 | |
| TLG1 > 14.068 | 18 | 5 (27.80) | |||
| Total | 48 | 27 (56.30) | |||
| Model 2 | TLG0 ≤ 1036.6 | ΔSUVmax ≥ 86.02% | 15 | 14 (93.3) | 0.547 |
| ΔSUVmax < 86.02% | 22 | 21 (95.5) | |||
| Total | 37 | 35 (94.6) | |||
| TLG0 > 1036.6 | ΔSUVmax ≥ 86.02% | 20 | 18 (90.0) | 0.000 | |
| ΔSUVmax < 86.02% | 28 | 9 (32.1) | |||
| Total | 48 | 27 (56.5) | |||
| Model 3 | NCCN‐IPI ≤ 3 | ΔSUVmax ≥ 86.02% | 23 | 22 (95.70) | 0.198 |
| ΔSUVmax < 86.02% | 26 | 21 (80.80) | |||
| Total | 49 | 43 (87.80) | |||
| NCCN‐IPI > 3 | ΔSUVmax ≥ 86.02% | 12 | 10 (83.30) | 0.009 | |
| ΔSUVmax < 86.02% | 24 | 9 (37.50) | |||
| Total | 36 | 19 (52.80) | |||
| Total | Total | 85 | 62 (72.90) |
NCCN‐IPI, National Comprehensive Cancer Network International Prognostic Index; PFS, progression‐free survival; SUVmax, maximum standardized uptake value; TLG, total lesion glycolysis (subscripts 0 and 1 represent baseline and interim measures, respectively).
a
Log‐rank test.